Financial statements Pharmavitae
Balance sheet data of PHARMAVITAE
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 264 594,09 | 197 078,09 | 450 793,26 | 681 000,12 | 1 155 245,16 | 472 615,06 |
| A. Fixed assets | 124 000,00 | 120 000,00 | 120 000,00 | 141 095,76 | 153 173,95 | 137 402,15 |
| B. Current assets | 140 594,09 | 77 078,09 | 330 793,26 | 539 904,36 | 1 002 071,21 | 335 212,91 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 264 594,09 | 197 078,09 | 450 793,26 | 681 000,12 | 1 155 245,16 | 472 615,06 |
| A. Equity | -522 279,84 | -505 822,41 | -655 344,87 | -912 297,32 | -1 503 613,13 | -1 956 941,29 |
| B. Liabilities and provisions for liabilities | 786 873,93 | 702 900,50 | 1 106 138,13 | 1 593 297,44 | 2 658 858,29 | 2 429 556,35 |
| I. Long-term liabilities | 619 948,20 | 642 370,70 | 676 782,74 | 585 290,66 | 515 523,05 | 529 496,04 |
| II. Short-term liabilities | 166 925,73 | 60 529,80 | 429 355,39 | 1 008 006,78 | 2 143 335,24 | 1 900 060,31 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.